SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says ...

Fig 1. Summary of key guideline recommendations. ADT, androgen deprivation therapy; ARPI, androgen receptor pathway inhibitor; C, conditional; CRPC, castration ...

A 75-year-old man, Mr. A, had prostate cancer that had metastasized to his pelvis and spine. Multiple anticancer drugs and hormone therapy to halt prostate cancer growth were attempted but ineffective ...

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly injecting an immune-activating compound into prostate tumors before surgery ...

Despite SBRT to oligometastatic sites, prostate cancer progression still occurs in a majority of patients due to occult microscopic disease.

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...